{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T10:12:58Z","timestamp":1791886378610,"version":"4.3.4"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T00:00:00Z","timestamp":1695859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173618"],"award-info":[{"award-number":["82173618"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673273"],"award-info":[{"award-number":["81673273"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["30600511"],"award-info":[{"award-number":["30600511"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec><jats:title>Objective<\/jats:title><jats:p>Older adults individuals have a higher risk of stroke recurrence, leading to high mortality and disability rates, which, in turn, hinders the achievement of healthy aging. This study aimed to assess the utility of a baseline sarcopenia index (SI) based on serum creatinine (Cr)\/cystatin C (CysC) as a prognostic marker for the risk of stroke recurrence and mortality in first-ever ischemic stroke older survivors (ISOS).<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and methods<\/jats:title><jats:p>Data were obtained from an ischemic stroke cohort study. The baseline information was collected from medical records and face-to-face interviews with patients admitted between January 2010 and June 2016. Follow-up information was obtained from telephone interviews every 3\u2009months to determine stroke recurrence and survival status. The SI was calculated from the Cr and CysC values in the medical records as Cr\/CysC\u2009\u00d7\u2009100. Using the first quantile of the SI as the cut-off value, the study participants were divided into the low muscle-mass group (low SI) and the high muscle-mass group (high SI). Cox regression analysis was used to assess the association between SI and recurrence and mortality.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 415 first-ever ISOS were enrolled, including 242 (58.31%) male and 173 (41.69%) female participants. In the high-SI group, the relapse and mortality rates were lower than those in the low-SI group (relapse: 20.58% vs. 30.77%; mortality:13.5% vs. 29.81%). After adjusting for confounding factors, the high-SI group was found to have a lower risk of relapse and mortality than the low-SI group (relapse: HR\u2009=\u20090.571; mortality: HR\u2009=\u20090.294).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The SI was predictive of the long-term prognosis of IS recurrence and mortality in first-ever ISOS. After discharge, in addition to conventional medication, it is recommended that patients with low SI values actively receive treatment for sarcopenia to reduce the risk of stroke recurrence and mortality and promote healthy aging.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fpubh.2023.1049738","type":"journal-article","created":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T13:18:58Z","timestamp":1695907138000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["A baseline sarcopenia index based on creatinine\/cystatin C for the prediction of stroke recurrence and mortality in older survivors of first ischemic strokes"],"prefix":"10.3389","volume":"11","author":[{"given":"Lisha","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cairong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,9,28]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"105736","DOI":"10.1016\/j.jstrokecerebrovasdis.2021.105736","article-title":"Measuring and monitoring skeletal muscle mass after stroke: a review of current methods and clinical applications","volume":"30","author":"Nakanishi","year":"2021","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1016\/s0140-6736(12)61728-0(2012)","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.2174\/1567202614666171116102504","article-title":"Cystatin C in cerebrovascular disorders","volume":"14","author":"Zhang","year":"2017","journal-title":"Curr Neurovasc Res"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1161\/CIR.0b013e3182009701","article-title":"Heart disease and stroke statistics\u20142011 update","volume":"123","author":"Roger","year":"2011","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1161\/STROKEAHA.111.000302","article-title":"Association of hypertension with stroke recurrence depends on ischemic stroke subtype","volume":"44","author":"Wang","year":"2013","journal-title":"Stroke"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1212\/wnl.48.4.891","article-title":"Stroke recurrence: predictors, severity, and prognosis","volume":"48","author":"J\u00f8rgensen","year":"1997","journal-title":"Copenhagen Stroke Study Neurol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1161\/strokeaha.114.005648","article-title":"Long-term mortality after first-ever and recurrent stroke in young adults","volume":"45","author":"Aarnio","year":"2014","journal-title":"Stroke"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"08002","DOI":"10.7189\/jogh.11.08002","article-title":"Health care reform and stroke prognosis in low-income Chinese populations from 1992 to 2018","volume":"11","author":"Liu","year":"2021","journal-title":"J Glob Health"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1161\/STROKEAHA.120.028992","article-title":"Risk and secondary prevention of stroke recurrence: a Population-Base cohort study","volume":"51","author":"Flach","year":"2020","journal-title":"Stroke"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(13)70255-2","article-title":"Secondary stroke prevention","volume":"13","author":"Hankey","year":"2014","journal-title":"Lancet Neurol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"104623","DOI":"10.1016\/j.jstrokecerebrovasdis.2019.104623","article-title":"Correlation between skeletal muscle mass deficit and poor functional outcome in patients with acute ischemic stroke","volume":"29","author":"Ohyama","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.nut.2019.04.011","article-title":"Prestroke sarcopenia and functional outcomes in elderly patients who have had an acute stroke: a prospective cohort study","volume":"66","author":"Nozoe","year":"2019","journal-title":"Nutrition"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"105259","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105259","article-title":"Low muscle mass is associated with walking function in patients with acute ischemic stroke","volume":"29","author":"Abe","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia:European consensus on definition and diagnosis: report of the European working group on sarcopenia in older people","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1093\/ageing\/afu115","article-title":"Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the international sarcopenia initiative (EWGSOP and IWGS)","volume":"43","author":"Cruz-Jentoft","year":"2014","journal-title":"Age Ageing"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1097\/CCM.0000000000002013","article-title":"Evaluating muscle mass by using markers of kidney function: development of the sarcopenia index","volume":"45","author":"Kashani","year":"2017","journal-title":"Crit Care Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"14028","DOI":"10.1038\/s41598-020-71028-4","article-title":"Serum creatinine\/cystatin C ratio as a case-finding tool for low handgrip strength in Chinese middle-aged and older adults","volume":"10","author":"Tan","year":"2020","journal-title":"Sci Rep"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.diabres.2018.02.025","article-title":"Decreased the creatinine to cysta-tin C ratio is a surrogate marker of sarcopenia in patients with type 2 diabetes","volume":"139","author":"Osaka","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s12603-020-1495-0","article-title":"Predictive value of serum creatinine\/cystatin C in acute ischemic stroke patients under nutritional intervention","volume":"25","author":"Liu","year":"2020","journal-title":"J Nutri Health Aging"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e01462","DOI":"10.1002\/brb3.1462","article-title":"Predictive value of serum creatinine\/cystatin C in neurocritically ill patients","volume":"9","author":"Wang","year":"2019","journal-title":"Brain Behav"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"13372","DOI":"10.1038\/s41598-021-92736-5","article-title":"Association between physical exercise and stroke recurrence among first-ever ischemic stroke survivors","volume":"11","author":"Hou","year":"2021","journal-title":"Sci Rep"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12603-021-1633-3","article-title":"The role of baseline sarcopenia index in predicting chemotherapy-induced undesirable effects and mortality in older people with stage III or IV non-small cell lung Cancer","volume":"25","author":"Chen","year":"2021","journal-title":"J Nutr Health Aging"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1007\/s40520-019-01170-1","article-title":"Malnutrition and sarcopenia","volume":"31","author":"Sieber","year":"2019","journal-title":"Aging Clin Exp Res"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/BMR-170801","article-title":"Dysphagia and aspiration pneumonia in elderly hospitalization stroke patients: risk factors, cerebral infarction area comparison","volume":"32","author":"Xu","year":"2019","journal-title":"J Back Musculoskelet Rehabil"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.21873\/anticanres.13203","article-title":"Adverse effects of preoperative sarcopenia on postoperative complications of patients with gastric Cancer","volume":"39","author":"Tamura","year":"2019","journal-title":"Anticancer Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"e0220699","DOI":"10.1371\/journal.pone.0220699","article-title":"Sarcopenia is an effective predictor of difficult-to-wean and mortality among critically ill surgical patients","volume":"14","author":"Kou","year":"2019","journal-title":"PloS One"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12877-017-0433-4","article-title":"Higher skeletal muscle mass may protect against ischemic stroke in community-dwelling adults without stroke and dementia: the PRESENT project","volume":"17","author":"Minn","year":"2017","journal-title":"BMC Geriatr"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/jcsm.12977","article-title":"Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer","volume":"13","author":"Tang","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1049738\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T13:19:01Z","timestamp":1695907141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2023.1049738\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,28]]},"references-count":28,"alternative-id":["10.3389\/fpubh.2023.1049738"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2023.1049738","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,28]]},"article-number":"1049738"}}